More pharmaceuticals IPOs expected after big response to Sihuan Pharma’s HK deal
Sihuan Pharmaceutical Holding Group has raised HK$5.8bn ($741m) after pricing an IPO at the top of its price range, and dealers now expect more listings for the pharmaceuticals sector.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts